Can aquaporins be used as diagnostic and prognostic markers for uterine smooth muscle tumours?

References

• Wallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol. 2004;104:393–406.2
   PubMed Web of Science ®Google Scholar
• Tsukada H, Muramatsu T, Miyazawa M, et al. Long term prognostic implications of expression of glucose transporter-1 and hexokinase II in patients with stage I uterine leiomyosarcoma. Acta Histochem Cytochem. 2012;45:147–154.
   PubMed Web of Science ®Google Scholar
• Amant F, Coosemans A, Debiec-Rychter M, et al. Clinical management of uterine sarcomas. Lancet Oncol. 2009;10:1188–198.
   PubMed Web of Science ®Google Scholar
• Gökaslan H, Türkeri L, Kavak ZN, et al. Differential diagnosis of smooth muscle tumors utilizing p53, pTEN and Ki-67 expression with estrogen and progesterone receptors. Gynecol Obstet Invest. 2005;59:36–40.
   PubMed Web of Science ®Google Scholar
• Poncelet C, Walker F, Madelenat P, et al. Expression of CD44 standard and isoforms V3 and V6 in uterine smooth muscle tumors: a possible diagnostic tool for the diagnosis of leiomyosarcoma. Hum Pathol. 2001;32:1190–1196.
   PubMed Web of Science ®Google Scholar
• Ünver NU, Acikalin MF, Öner Ü, et al. Differential expression of P16 and P21 in benign and malignant uterine smooth muscle tumors. Arch Gynecol Obstet. 2011;284:483–490.
   PubMed Web of Science ®Google Scholar
• Verkman AS, Mitra AK. Structure and function of aquaporin water channels. Am J Physiol Renal Physiol. 2000;278:13–28.
   PubMed Web of Science ®Google Scholar
• King LS, Kozono D, Agre P. From structure to disease: the evolving tale of aquaporin biology. Nat Rev Mol Cell Biol. 2004;5:687–698.
   PubMed Web of Science ®Google Scholar
• Saadoun S, Papadopoulos MC, Hara-Chikuma M, et al. Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption. Nature. 2005;434:786–792.
   PubMed Web of Science ®Google Scholar
• Hu J, Verkman AS. Increased migration and metastatic potential of tumor cells expressing aquaporin water channels. FASEB J. 2006;20:1892–1894.
   PubMed Web of Science ®Google Scholar
• Verkman AS, Hara-Chikuma M, Papadopoulos MC. Aquaporins new players in cancer biology. J Mol Med (Berl). 2008;86:523–529.
   PubMed Web of Science ®Google Scholar
• Prat J. FIGO staging for uterine sarcomas. Int J Gynaecol Obstet. 2009;104:177–178.
   PubMed Web of Science ®Google Scholar
• Yang C, Wang S, Li CC, et al. Ovarian germ cell tumors in children: a 20-year retrospective study in a single institution. Eur J Gynaecol Oncol. 2011;32:289–192.
   PubMed Web of Science ®Google Scholar
• Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol. 1994;18:535–558.
   PubMed Web of Science ®Google Scholar
• Downes KA, Hart WR. Bizarre leiomyomas of the uterus: a comprehensive pathologic study of 24 cases with long-term follow-up. Am J Surg Pathol. 1997;21:1261–1270.
   PubMed Web of Science ®Google Scholar
• Kefeli M, Yildiz L, Kaya FC, et al. Fascin expression in uterine smooth muscle tumors. Int J Gynecol Pathol. 2009;28:328–333.
   PubMed Web of Science ®Google Scholar
• Özler A, Evsen MS, Turgut A, et al. CD147 expression in uterine smooth muscle tumors, and its potential role as a diagnostic and prognostic marker in patients with leiomyosarcoma. J Exp Ther Oncol. 2014;10:325–330.
   PubMedGoogle Scholar
• Kaur K, Kaur P, Kaur A, Singla A. Uterine leiomyosarcoma: a case report. J Midlife Health. 2014;5:202–204.
   PubMedGoogle Scholar
• Zivanovic O, Leitao MM, Iasonos A, et al. Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the International Federation of Gynecology and Obstetrics and American Joint Committee on Cancer Staging Systems. J Clin Oncol. 2009;27:2066–2072.
   PubMed Web of Science ®Google Scholar
• Sait HK, Anfinan NM, El Sayed ME, et al. Uterine sarcoma. Clinico-pathological characteristics and outcome. Saudi Med J. 2014;35:1215–1222.
   PubMed Web of Science ®Google Scholar
• Leibsohn S, d'Ablaing G, Mishell DR Jr, et al. Leiomyosarcoma in series of hysterectomies performed for presumed uterine leiomyomas. Am J Obstet Gynecol. 1990;162:968–974.
   PubMed Web of Science ®Google Scholar
• D'Angelo E, Prat J. Uterine sarcomas: a review. Gynecol Oncol 2010;116:131–139.
   PubMed Web of Science ®Google Scholar
• King IS, Agre P. Pathophysiology of the aquaporin water channels. Annu Rev Physiol. 1996;58:619–648.
   PubMed Web of Science ®Google Scholar
• Skowronski MT. Distribution and quantitative changes in amounts of aquaporin 1, 5 and 9 in the pig uterus during the estrous cycle and early pregnancy. Reprod Biol Endocrinol. 2010;8:109.
   PubMed Web of Science ®Google Scholar
• Litman T, Sogaard R, Zeuthen T. Ammonia and urea permeability of mammalian aquaporins. Handb Exp Pharmacol. 2009;190:327–358.
   PubMedGoogle Scholar
• Wang G, Gao F, Zhang W, et al. Involvement of aquaporin 3 in Helicobacter pylori-related gastric diseases. PLoS One. 2012;7:e49104.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wang Y, Wen J, et al. Aquaporin 3 promotes the stem-like properties of gastric cancer cells via Wnt/GSK-3β/β-catenin pathway. Oncotarget. 2016;7:16529–16541.
   PubMed Web of Science ®Google Scholar
• Kusayama M, Wada K, Nagata M, et al. Critical role of aquaporin 3 on growth of human esophageal and oral squamous cell carcinoma. Cancer Sci. 2011;102:1128–1136.
   PubMed Web of Science ®Google Scholar
• Shi YH, Chen R, Talafu T, et al. Significance and expression of aquaporin 1, 3, 8 in cervical carcinoma in Xinjiang Uygur women of China. Asian Pac J Cancer Prev. 2012;13:1971–1975.
   PubMed Web of Science ®Google Scholar
• Niu D, Kondo T, Nakazawa T, et al. Differential expression of aquaporins and its diagnostic utility in thyroid cancer. PLoS One. 2012;7:e40770.
   Google Scholar
• Liu W, Wang K, Gong K, et al. Epidermal growth factor enhances MPC-83 pancreatic cancer cell migration through the upregulation of aquaporin 3. Mol Med Rep. 2012;6:607–610.
   PubMed Web of Science ®Google Scholar
• Ismail M, Bokaee S, Morgan R, et al. Inhibition of the aquaporin 3 water channel increases the sensitivity of prostate cancer cells to cryotherapy. Br J Cancer. 2009;100:1889–1895.
   PubMed Web of Science ®Google Scholar
• Chen J, Wang Z, Xu D, et al. Aquaporin 3 promotes prostate cancer cell motility and invasion via extracellular signal-regulated kinase 1/2-mediated matrix metalloproteinase-3 secretion. Mol Med Rep. 2015;11(4):2882–2888.
   PubMed Web of Science ®Google Scholar
• Ji C, Cao C, Lu S, et al. Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells. Cancer Chemother Pharmacol. 2008;62:857–865.
   PubMed Web of Science ®Google Scholar
• Hara-Chikuma M, Verkman AS. Prevention of skin tumorigenesis and impairment of epidermal cell proliferation by targeted aquaporin-3 gene disruption. Mol Cell Biol. 2008;28:326–332.
   PubMed Web of Science ®Google Scholar
• Seleit I, Bakry OA, Al Sharaky D, et al. Evaluation of aquaporin-3 role in nonmelanoma skin cancer: an immunohistochemical study. Ultrastruct Pathol. 2015;39:306–317.
   PubMed Web of Science ®Google Scholar
• Wakayama Y, Hirako S, Ogawa T, et al. Upregulated expression of AQP 7 in the skeletal muscles of obese ob/ob mice. Acta Histochem Cytochem. 2014;47:27–33.
   PubMed Web of Science ®Google Scholar
• Lacroix L, Lazar V, Michiels S, et al. Follicular thyroid tumors with the PAX8-PPAR gamma1 rearrangement display characteristic genetic alterations. Am J Pathol. 2005;167:223–231.
   PubMed Web of Science ®Google Scholar
• Warth A, Mittelbronn M, Hulper P, et al. Expression of the water channel protein aquaporin-9 in malignant brain tumors. Appl Immunohistochem Mol Morphol 2007;15:193–198.
   PubMedGoogle Scholar
• Jablonski EM, Mattocks MA, Sokolov E, et al. Decreased aquaporin expression leads to increased resistance to apoptosis in hepatocellular carcinoma. Cancer Lett. 2007;250:36–46.
   PubMed Web of Science ®Google Scholar